Indusatumab GUCY2C: A Deep Dive into 1497400-26-6 Indusatumab GUCY2C, identified through the chemical identifier 1497400-26-6, is a innovative antibody-drug compound currently under clinical study. This particular molecule combines an GUCY2C-targeting immunoglobulin with a cytotoxic pay

Ocrelizumab: A Deep Dive into IDC-2403's Mechanism Ocrelizumab, initially investigated as IDC-2403, demonstrates a unique mechanism of action targeting b cells, essential in the manifestation of several sclerosis & related disorders . It specifically binds to the CD20 protein found on n